CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.

1:17-cv-00410

Overview

Case Number 1:17-cv-00410
Filing Date 2017-04-10
Status Terminated
Termination Date 2017-09-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Bristol-Myers Squibb Company NPE (Individual / Inventor)

Represented By

10 Attorneys Listed

Timothy A. Cook

Email: tim.cook@wilmerhale.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Andrew J. Danford

Email: andrew.danford@wilmerhale.com

Tracey C. Allen

UNDELIVERABLE EMAIL 6/16/2021

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Kevin M. Yurkerwich

Email: kevin.yurkerwich@wilmerhale.com

Heather M. Petruzzi

Email: heather.petruzzi@wilmerhale.com

Jeffrey T. Hantson

Email: jeffrey.hantson@wilmerhale.com

Amy K. Wigmore

Email: amy.wigmore@wilmerhale.com

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

4 Attorneys Listed

Mark D. Schuman

UNDELIVERABLE EMAIL 8/30/2019

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Todd S. Werner

Email: werner@avantechlaw.com

Nathan D. Louwagie

Email: nlouwagie@carlsoncaspers.com

Pfizer Inc. Operating Company

Represented By

3 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2018-04-05
IPR2018-00892

Mylan Pharmaceuticals Inc. v. Pfizer Inc.

Asserted Patent
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9326945
Apixaban formulations
Filed: 2011-02-24
Issued: 2016-05-03
Active (4.3 yrs remaining)
Expires: 2031-02-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Docket Entries

(23 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119534.) - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 04/11/2017)

Entry #1 • 2017-04-10
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119534.) - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 04/11/2017)

Entry #1 • 2017-04-10
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119534.) - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 04/11/2017)

Entry #1 • 2017-04-10
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119534.) - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 04/11/2017)

Entry #1 • 2017-04-10
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 04/11/2017)

Entry #2 • 2017-04-10
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc